TY - JOUR
T1 - Lack of Behavioral Supersensitivity to d-Amphetamine after Pimozide Withdrawal
T2 - A Trial with Schizophrenic Patients
AU - van Kammen, Daniel P.
AU - Docherty, John P.
AU - Marder, Stephen R.
AU - Schulz, S. Charles
AU - Bunney, William E.
PY - 1980/3
Y1 - 1980/3
N2 - The dopamine hypothesis of schizophrenia claims that increased dopamine activity underlies psychotic behavior. This hypothesis gets major support from the reported d-amphetamine-induced worsening of psychosis, because amphetamine increases dopamine activity in the brain. Dopamine receptor supersensitivity has been shown to be present in animals during the postneuroleptic period. In this study the postulated relationships between psychotic decompensation as observed after d-amphetamine infusion and the dopamine receptor supersensitivity expected to be present during the neuroleptic withdrawal period were examined. Twenty milligrams of d-amphetamine administered intravenously did not cause a stronger psychotogenic effect in 12 schizophrenic patients. One week after discontinuation of pimozide treatment, the d-amphetamine-induced change as indicated by the Brief Psychiatric Rating Scale (BPRS) paranoid disturbance cluster score, was not significantly different from the response to a similar infusion during the drug-free state. Unexpectedly, the increase in the BPRS mannerisms and posturing item and in the pulse rate response to d-amphetamine were decreased. These results raise questions about the role of dopamine in d-amphetamine effects and suggest postneuroleptic dopamine receptor subsensitivity. They challenge a simple dopamine hypothesis of schizophrenia.
AB - The dopamine hypothesis of schizophrenia claims that increased dopamine activity underlies psychotic behavior. This hypothesis gets major support from the reported d-amphetamine-induced worsening of psychosis, because amphetamine increases dopamine activity in the brain. Dopamine receptor supersensitivity has been shown to be present in animals during the postneuroleptic period. In this study the postulated relationships between psychotic decompensation as observed after d-amphetamine infusion and the dopamine receptor supersensitivity expected to be present during the neuroleptic withdrawal period were examined. Twenty milligrams of d-amphetamine administered intravenously did not cause a stronger psychotogenic effect in 12 schizophrenic patients. One week after discontinuation of pimozide treatment, the d-amphetamine-induced change as indicated by the Brief Psychiatric Rating Scale (BPRS) paranoid disturbance cluster score, was not significantly different from the response to a similar infusion during the drug-free state. Unexpectedly, the increase in the BPRS mannerisms and posturing item and in the pulse rate response to d-amphetamine were decreased. These results raise questions about the role of dopamine in d-amphetamine effects and suggest postneuroleptic dopamine receptor subsensitivity. They challenge a simple dopamine hypothesis of schizophrenia.
UR - http://www.scopus.com/inward/record.url?scp=0018886466&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0018886466&partnerID=8YFLogxK
U2 - 10.1001/archpsyc.1980.01780160057006
DO - 10.1001/archpsyc.1980.01780160057006
M3 - Article
C2 - 6102456
AN - SCOPUS:0018886466
SN - 0003-990X
VL - 37
SP - 287
EP - 290
JO - Archives of General Psychiatry
JF - Archives of General Psychiatry
IS - 3
ER -